Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-22-006826

President and CEO acquired 10,800 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Walker Neal President and CEO 2022-02-01 Option exercise +10,800 1,242,982 D
Derivatives
Walker Neal President and CEO 2022-02-01 Option exercise · Restricted Stock Units −10,800 0 D
Loading xslF345X03/doc4.xml…